Search Constraints
Search Results
Select an image to start the slideshow
A Genetically engineered second-generation clot dissolver containing uPA-B chain fused to factor XI is active in plasminogen activator assays
1 of 17
The Presence of DNA-binding protein LSF in a complex that binds to the switch region of immunoglobulin heavy chain gene gamma 3
2 of 17
Investigation of HN protein function during paramyxovirus infection using site-directed mutagenesis
3 of 17
Prohormone convertase 2 as a biomarker for neuroendocrine lung tumors -- detection of gene products in PreservCyt solutions
4 of 17
Post-operative pain
5 of 17
Cytokine production in a rat model of diabetes in response to treatment with poly IC
6 of 17
Ischaemic preconditioning enhances postischaemic recovery in the rat heart
7 of 17
Differences in the gene expression of osteopetrotic toothless (tl) rats, colony stimulating factor 1 (CSF-1) treated tl rats, and their normal littermates as determined by differential display
8 of 17
Yeast two-hybrid of PIE-1 in C. elegans
9 of 17
Sequence analysis of CP and NCP HIV-1 clones
10 of 17
Investigation of the effect of GLA and ajulemic acid on the production of MMP-1, MMP-3, and MMP-9 in synovial fibroblasts
11 of 17
Development of a cell lysis assay for natural killer cells
12 of 17
Transforming growth factor- and prostate cancer
13 of 17
The Activator protein-1 upregulated by neurotrophic peptides NMI-9236 and NMI-8933 is capable of transcriptional trans-activation
14 of 17
The effects of circadian rhythm and low-dose irradiation (100cGy) on murine bone marrow transplantation
15 of 17
Characterization of a novel gene in a transgenic mouse model of Huntington's disease
16 of 17
Betafectin immunomodulator increases the activities of JNK and IKK kinases and increases the nuclear translocation of AP-1 in macrophage cells
17 of 17